Screening in Obstetrics & Gynecology: Management of Abnormality

by Pandey Alka, Magon Navneet

This book ‘Screening in Obstetrics and Gynecology Management of Abnormality’ describe screening as an important tool in obstetrics and gynecology to reduce morbidity and mortality both in the woman and the fetus. Fetal anemia is a complication in pregnancies and can be due to anti-Rh (D), anti-Rh (c) and anti-Kell (K1). Among these, ABO and Rh antigens are the most commonly tested antigens. Specific tests like serum ferritin level, erythrocyte protoporphyrin level, and serum transferrin receptors level are carried out for assessing antepartum iron status. Asymptomatic bacteriuria mostly caused by E.coli, if untreated, increases the risk of UTI. Antenatal HCV test is done to identify asymptomatic women with chronic disease. Genetic Sonogram is done to check aneuploidy in the fetus. Common aneuploidies include trisomy 21, trisomy 13 and 18 (Edward syndrome), Turner syndrome, Triploidy and the sex chromosome anomalies. Thrombophilias in pregnancy can be hereditary or acquired or sometimes mixed. Intrauterine growth restriction can be detected by the use of customised SFH charts, standardized techniques and protocols and managed by color Doppler velocimetry. Screening for spontaneous preterm labor and delivery, fetal hypoxia, menopause, contraceptive users, cervical cancer, ovarian cancer, thyroid disorders, and hemoglobinopathy is discussed. In addition, breast cancer screening, peripartum coagulopathy, postpartum anemia as well as genetic predisposition to gynecological and breast cancers are described.

Download